Read More

Nano-Cap Eledon Pharmaceuticals’ Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence

Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and efficacy in kidney transplant patients. Analysts anticipate significant advancements, reflecting in raised price targets.

ELDN

Read More

Cannabis Co. C21 Investments Secures Funding For $3.5M Acquisition Of Nevada’s Deep Roots Harvest

C21 Investments announced on Monday the closing of its non-brokered private placement offering of its convertible debenture units.Under the deal, the company issued a total of 4,000 convertible debenture units at CA$1,000 ($731.375) per convertible debenture unit for aggregate gross proceeds of CA$4 million.Each convertible debenture unit offered under the private placement is comprised of one convertible debenture of the company in the principal amount of CA$1,000 convertible into the company's common shares and 1,000 detachable common share purchase warrants, with each warrant exercisable into one common share at CA$0.55 per share for 30 months from the issue date of the convertible debenture units.

CSE:CXXI

Read More

Canopy Growth Announces Financing Deal Including Roughly $50M Of New Gross Proceeds

Canopy Growth Corporation has entered into an exchange and subscription agreement with a single institutional investor under which the Smiths Falls, Ontario-based company is expected to receive gross proceeds of roughly $50 million and exchange approximately CA$27.5 million ($20 million) of existing debt maturing in September 2025 for a new senior unsecured convertible debenture of the company maturing five years following the day of issuance. Under the terms of the deal, the investor will acquire a convertible debenture in an aggregate principal amount equal to CA$96,358,375 on closing.

CGC

Read More

Kline Hill Invests In Complete Solaria With Debt-Equity Swap, And An Additional Cash Investment; Complete Solaria Will Issue 9.8M Shares Of Outstanding Stock To KHP In Return For Cancelling Its Debt; Kline Hill Also Agreed To Buy 3.7M Complete Solaria…

Complete Solaria, Inc. ("Complete Solaria" or the "Company") (NASDAQ:CSLR) today announced that Kline Hill Partners (KHP), a Complete Solaria debt holder, has agreed to a debt-for-equity swap, and an additional cash

CSLR

Read More

Blend Labs Announces Strategic Partnership With Haveli Investments, Including $150M Investment In The Form Of Convertible Preferred Stock With A 0% Coupon; Will Use ~$145M Of The Proceeds To Repay All Amounts Payable Under Its Existing Credit Agreement…

Brian Sheth, Haveli's Chief Investment Officer, to Join Blend's BoardBlend Labs, Inc. (NYSE:BLND), ("Blend" or the "Company"), a leading provider of cloud banking services,and Haveli Investments ("Haveli"), a

BLND